amyloid and tau

The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.

Researchers used sound waves to jiggle a temporary opening in the brain's protective shield for three patients over six months. In spots where that shield was opened, more plaque was cleared.

Sarasota's Roskamp Institute was the first to discover a protein that tends to form clumps in the brains of people with Alzheimer's. A new drug has been shown to reduce it.

Researchers are using brain scans, blood and spinal fluid to detect early signs of Alzheimer's disease. These "biomarkers" may also offer a quicker way to test new Alzheimer's drugs.

Sticky plaque gets the most attention, but now healthy seniors at risk of Alzheimer’s are letting scientists peek into their brains to see if another…